WillItSurvive
Pharma and healthcare groups · United States

Henry Schein

henryschein.com ↗

Henry Schein distributes dental and medical supplies and runs Dentrix, the practice software most dentists use.

Hard to displace
Assessed 20 July 2026 · Evidence as of 20 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 20 July 2026 · Checkable from August 3-4, 2026 · Every call on the record Checkpoint: Q2 2026 earnings call, first full quarter under new CEO Fred Lowery
The call

Henry Schein sits inside a three-company dental distribution setup that AI has not cracked, and it is now selling AI tools through Dentrix rather than losing ground to them.

Henry Schein is the largest distributor of dental supplies and practice management software to US dentists and dental offices, competing mainly against Patterson and Benco. It is hard to replace because of three things: it has spent decades building relationships with regulators and practices, it controls the software that dental offices use to run their business (called Henry Schein One), and new competitors would have to build logistics networks and get licenses to handle controlled drugs like painkillers, which is expensive and slow. The one thing that could change this is if younger, cloud-based dental software companies like Overjet or Curve start pulling mid-size dental groups away from Henry Schein's practice management software, though this is not happening yet.

Why
01
AI pressure: Overjet and other AI-native dental imaging or cloud practice-management startups. AI imaging tools could bypass Dentrix, but none have pulled meaningful DSO share from Dentrix Ascend yet. Could AI do the core job? Unlikely.
02
Bigger players: Amazon Business. Amazon could undercut Henry Schein on commodity consumables, but full dental distribution needs compliance, financing, and logistics Amazon hasn't built. Could a giant copy it? No, they are blocked.
03
What protects it. Dentrix runs 100,000+ practices and 90% of DSOs, and switching practice software mid-workflow is costly and disruptive.
What would change this call
Overjet, Curve, or Open Dental announces a named DSO win moving off Dentrix Ascend. would show cloud-native rivals are actually displacing Henry Schein One, not just competing on paper.
Amazon Business or McKesson/Cardinal Health launches a full-service dental equipment plus financing offering. would show a healthcare distributor breaching the oligopoly's integrated moat.
Henry Schein Q2/Q3 2026 earnings show Dentrix Ascend or DSO customer count growth stalling or reversing. would show early erosion of the software lock-in underpinning the moat.
Key numbers
  • FY2025 sales $13.18-13.2B, up ~4% YoY (2025-12-31)
  • Henry Schein, Patterson, Benco hold 85%+ of US dental distribution (2021-07-06)
  • Dentrix platform handles 120M+ claims per year (2026-04-28)
Named risks
  • Recurrence of a major HIPAA-environment cybersecurity breach after 2023 ransomware attack and 2025 settlement. Severity: high
  • AI-native dental practice-management or imaging upstarts (Overjet, Curve, Open Dental) eroding Dentrix Ascend's DSO base. Severity: medium
  • New external CEO Fred Lowery (since March 2026) shifting or abandoning the BOLD+1 growth strategy. Severity: medium
  • Amazon Business or a peer distributor building a full-service dental offering with equipment, compliance, and financing. Severity: low
  • Ongoing antitrust scrutiny of the Schein-Patterson-Benco dental distribution structure (FTC Docket 9379 legacy). Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Patterson Companiescontestingco-holds ~85%+ of US dental distribution oligopoly with Schein per FTC matter, 2021-07-06
Benco Dentalcontestingthird member of the ~85%+ dental distribution oligopoly alongside Schein and Patterson
Amazon Businessgaining onnibbling at commodity dental consumables distribution margins as of 2026, no full-service offering yet
Overjetcontestingcited as potential AI-native imaging threat to Dentrix Ascend; no visible share displacement shipped as of 2026
Curve Dental / Open Dentalcontestingnamed as possible cloud-native practice-management upstarts, not yet materializing share loss in 2026
Questions people ask
Is Henry Schein profitable in 2026?
Yes. For Q1 2026 (quarter ended March 28, 2026), Henry Schein reported revenue of $3.37 billion, up 6.3% year over year, with non-GAAP diluted EPS of $1.32 versus $1.15 the prior year, beating consensus estimates, per its May 5, 2026 earnings release.
Could AI replace Henry Schein's distribution or software business?
Unlikely soon. Henry Schein is embedding AI as an ingredient rather than being disrupted: Henry Schein One partnered with AWS on generative AI in November 2025 and opened an MCP layer for AI agents in Dentrix Ascend on April 28, 2026, reinforcing its proprietary-data lock-in with 100,000+ practices.
Who is Henry Schein's biggest competitor?
Patterson Companies and Benco Dental. Together with Henry Schein, these three control roughly 85%+ of full-service US dental distribution, a structure detailed in an FTC matter (Docket 9379) referenced as of July 6, 2021.
Who owns Henry Schein?
Henry Schein is publicly traded on Nasdaq under HSIC, with a market cap of roughly $9.5 to $10.1 billion as of mid-July 2026. KKR is a strategic investor with board representation, as noted in the January 12, 2026 CEO announcement.
Did Henry Schein have a data breach?
Yes. A 2023 BlackCat/ALPHV ransomware attack allegedly stole 35TB of data affecting over 166,000 individuals. Henry Schein finalized a $2.9 million class-action settlement over the breach on January 21, 2025.
What is Henry Schein's revenue guidance for 2026?
Henry Schein guided to total sales growth of about 3-5% over 2025, revenue of $13.6-13.8 billion, and non-GAAP diluted EPS of $5.23-$5.37, issued alongside its Q4/FY2025 results on February 24, 2026.
Timeline
  • 2026-07-16HSIC stock hits new 1-year high; market cap roughly $9.5 to $10.1 billion
  • 2026-05-21William 'Dan' Daniel becomes Independent Chairman, board reduced to 10 directors
  • 2026-04-30Dentrix Ascend launches Next Generation Clinical Workflow with voice AI and image analysis
  • 2026-04-28Dentrix Ascend opens MCP layer enabling third-party AI agents
  • 2026-03-28Q1 2026 quarter ends; revenue $3.37 billion, up 6.3% year over year
  • 2026-03-02Frederick Lowery becomes CEO, succeeding Stanley Bergman after 35 years
  • 2026-02-24Henry Schein reports FY2025 results and issues 2026 guidance
  • 2026-01-12Henry Schein names Frederick Lowery as incoming CEO
  • 2025-11-03Henry Schein One and AWS announce generative AI partnership
  • 2025-01-21Henry Schein finalizes $2.9 million ransomware breach class-action settlement
Revision history
20 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Vertex PharmaceuticalsTenet HealthcareIntuitive Surgical
More in Pharma and healthcare groups →
Sources